Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas

NCT03042819 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: Selinexor
DRUG: Doxorubicin

Sponsor

University Health Network, Toronto

Collaborators

[object Object]